Amira Hanafy

Forschungsprofil¹
Visitenkarte²

Dr. Amira Hanafy

Zugehörigkeiten

AK Lamprecht

Forschungsschwerpunkte

Blood Brain Barrier

I am passionate about the blood-brain barrier and brain-targeted drug delivery. My current DFG-funded project investigates innovative therapeutic targets for managing Alzheimer’s disease. I have received several grants and fellowships to support my research, including the Georg Forster Postdoctoral Fellowship from the Alexander von Humboldt Foundation and BONFOR funding at the University Hospital Bonn. In 2025, I was awarded the BONFOR Commission’s prize for the best project at the University Hospital Bonn, recognizing my work on perinatal BBB permeability fluctuations in the striatum.

Ausgewählte Publikationen

Hanafy AS. (2025). Revisiting cerebral endothelial cells in Alzheimer's disease. Neural Regeneration Research. 20(10): 2911-2912. DOI: 10.4103/NRR.NRR-D-24-00640
Hanafy AS, Lamprecht A, Dietrich D. (2023). Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer’s model. Fluids and Barriers of the CNS. 20(1): 85. DOI: 10.1186/s12987-023-00492-7
Hanafy AS, Steinlein P, Pitsch J, Silva MH, Vana N, Becker A, Graham ME, Schoch S, Lamprecht A, Dietrich Dǂ. (2023). Subcellular analysis of blood-brain barrier function by micro-impalement of vessels in acute brain slices. Nature Communications. 14(1): 481. DOI: 10.1038/s41467-023-36070-6
Hanafy AS, Dietrich D, Fricker G, Lamprecht A. (2021). Blood-brain barrier models: rationale for selection. Advanced Drug Delivery Reviews. 176: 113859. DOI: 10.1016/j.addr.2021.113859
ElGanainy S, Gowayed M, Agami M, Mohamed P, Belal M, Farid R, Hanafy AS. (2021). Galantamine nanoparticles outperform oral galantamine in an Alzheimer’s rat model: pharmacokinetics and pharmacodynamics. Nanomedicine. 16(15): 1281-1296. DOI: 10.2217/nnm-2021-0051

Dr. Amira Hanafy

amira.hanafy@uni-bonn.de

+49 228 73 5244

+49

1.036

Gerhard-Domagk-Straße 3

53121 Bonn

Links